Sign In
Buy ADIL
$2.71
+0.110 (+4.23%)
At Close: Jun 22, 2026
Adial Pharmaceuticals Provides Regulatory and Development Update
05:07pm, Thursday, 24'th Jun 2021
CHARLOTTESVILLE, Va., June 24, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addic
Top 10 Biotech Penny Stocks to Watch in July 2021
04:24pm, Tuesday, 22'nd Jun 2021
Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News a
ADIL Stock Price Increases Over 30% Pre-Market: Why It Happened
04:59am, Tuesday, 22'nd Jun 2021
The stock price of Adial Pharmaceuticals Inc (NASDAQ: ADIL) increased by over 30% pre-market. This is why it happened.
Adial Pharmaceuticals Featured on Multiple News Broadcasts Nationwide Regarding the Second Pandemic of Alcohol Use Disorder
01:19pm, Tuesday, 18'th May 2021
CHARLOTTESVILLE, Va., May 18, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatme
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
03:05pm, Friday, 26'th Feb 2021
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatm
Adial to File Fast Track Application for AD04 with the FDA
01:00pm, Tuesday, 23'rd Feb 2021
CHARLOTTESVILLE, Va., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
11:00am, Monday, 11'th Jan 2021
CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
09:50am, Monday, 11'th Jan 2021
CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictio
Adial Pharmaceuticals: Opportunity Knocks For Micro Cap Targeting Multi-Billion Alcohol Use Disorder Market (NASDAQ:ADIL)
07:53pm, Saturday, 17'th Oct 2020
Adial is a tiny microcap attempting to convert an approved nausea and sickness treatment, Ondansetran, into a treatment for alcohol use disorder.
Why Adial's Stock Is Trading Lower Today
12:00am, Wednesday, 30'th Sep 2020
Adial Pharmaceuticals (NASDAQ: ADIL) shares are trading lower on Wednesday, potentially selling off after surging on Tuesday following FDA emergency use authorization for the...
Why Adial Pharmaceuticals Is Trading Higher Today
12:00am, Tuesday, 29'th Sep 2020
Adial Pharmaceuticals (NASDAQ: ADIL) shares are trading higher on Tuesday after the company announced the FDA has issued an emergency use authorization for the company's...
Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits
01:30pm, Thursday, 06'th Aug 2020
CHARLOTTESVILLE, VA / ACCESSWIRE / August 6, 2020 / Adial Pharmaceuticals, Inc.
LD Micro Announces Preliminary List of Presenters for the LD 500
01:00pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
